Shigeko Satomura Selected Research

Methyl-CpG-Binding Protein 2

1/2012

Concomitant microduplications of MECP2 and ATRX in male patients with severe mental retardation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeko Satomura Research Topics

Disease

2	Epilepsy (Aura) 01/2017 - 11/2014
2	Intellectual Disability (Idiocy) 01/2017 - 01/2012
2	Seizures (Absence Seizure) 06/2016 - 11/2014
1	Sarcopenia 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Mobility Limitation (Difficulty Walking) 01/2020
1	Drug Resistant Epilepsy 01/2017
1	Myoclonus (Nocturnal Myoclonus) 11/2014
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 11/2014
1	alpha-Thalassemia 01/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2002

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2016
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2017 - 11/2014
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 11/2014
1	CreatinineIBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2017
1	AntioxidantsIBA 06/2016
1	AlbuminsIBA 06/2016
1	Methyl-CpG-Binding Protein 2IBA 01/2012
1	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2017